A Randomized, Double-Blind Clinical Study on Blood Pressure Reduction and Blood Lipid Profile Amelioration on Treatment with Ankascin 568

10.4077/CJP.2017.BAF452

Chien-Li Chen；Jen-Ho Tseng；Tzu-Ming Pan；Sheng-Huang Hsiao

ankaflavin ； Ankascin 568 ； hypertension ； monascin ； Monascus purpureus NTU 568

The Chinese Journal of Physiology

60卷3期（2017 / 06 / 30）

158 - 165

英文

Hypertension and cardiovascular complications are the leading causes of death worldwide. Antihypertensive drugs often cause various side effects, and improper use of antihypertensive medications can result in irreparable damage. Edible fungi of the Monascus species have been used as traditional Chinese medicines in Southeast Asia for several centuries. The fermented products of Monascus purpureus NTU 568 (ANKASCIN 568) possess a number of functional secondary metabolites including the anti-inflammatory pigments monascin (MS) and ankaflavin (AK). In this study, a double-blind, placebo-controlled clinical trial was performed in which patients with mild to moderate hypertension were randomly assigned to receive placebo or two 500-mg capsules of Ankascin 568 for 8 weeks. The effects of this treatment on the regulation of blood pressure (BP) were then examined. The results showed that systolic blood pressure (SBP) decreased from 141.6 ± 12.0 to 133.9 ± 14.4 mmHg (P ＜ 0.05), and diastolic blood pressure (DBP) decreased from 91.7 ± 8.1 to 84.8 ± 7.4 mmHg (P ＜ 0.05). Moreover, Ankascin 568 treatment effectively reduced serum triglycerides and total cholesterol (TC), increased high-density lipoprotein cholesterol (HDL-C), and reduced low-density lipoprotein cholesterol (LDL-C) levels, thereby improving the serum lipid profile. Additionally, administration of Ankascin 568 did not cause significant rhabdomyolysis nor impaired the metabolic or physiological functions of the liver or kidney. In conclusion, patients administered Ankascin 568 for 8 weeks exhibited significant in reduction of SBP, serum TC and LDL-C levels, which should contribute to better cardiovascular health.

1. Blanc, P.J.,Loret, M.O.,Goma, G.(1995).Production of citrinin by various species of Monascus.Biotechnol. Lett.,17,291-294.
2. Chan, C.W.H.,Thompson, D.R.(2006).The use of placebo in clinical nursing research.J. Clin. Nurs.,15,521-524.
3. Chen, C.H.,Yang, J.C.,Uang, Y.S.,Lin, C.J.(2013).Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.Int. J. Pharm.,444,18-24.
4. Chen, C.L.,Pan, T.M.(2012).Red mold dioscorea: a potentially safe traditional function food for the treatment of hyperlipidemia.Food Chem.,134,1074-1080.
5. Chen, C.L.,Pan, T.M.(2013).Red mold dioscorea decreases blood pressure when administered alone or with amlodipine and is a potentially safe functional food in SHR and WKY rats.J. Funct. Foods,5,1456-1465.
6. Chobanian, A.V.,Bakris, G.L.,Black, H.R.,Cushman, W.C.,Green, L.A.,Izzo, J.L., Jr.,Jones, D.W.,Materson, B.J.,Oparil, S.,Wright, J.T., Jr.,Roccella, E.J.,National High Blood Pressure Education Program Coordinating Committee(2003).Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.Hypertension,42,1206-1252.
7. Endo, A.(1980).Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.J. Antibiot.,33,334-336.
8. Fleckenstein-Grun, G.,Frey, M.,Thimm, F.,Fleckenstein, A.(1992).Protective effects of various calcium antagonists against experimental arteriosclerosis.J. Hum. Hypertens.,6,13-18.
9. Furukawa, S.,Fujita, T.,Shimabukuro, M.,Iwaki, M.,Yamada, Y.,Nakajima, Y.,Nakayama, O.,Makishima, M.,Matsuda, M.,Shimomura, I.(2004).Increased oxidative stress in obesity and its impact on metabolic syndrome.J. Clin. Invest.,114,1752-1761.
10. Hsu, W.H.,Lee, B.H.,Liao, T.H.,Hsu, Y.W.,Pan, T.M.(2012).Monascus-fermented metabolite monascin suppresses inflammation via PPAR-c regulation and JNK inactivation in THP-1 monocytes.Food Chem. Toxicol.,50,1178-1186.
11. Hsu, W.H.,Liao, T.H.,Lee, B.H.,Hsu, Y.W.,Pan, T.M.(2013).Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ activation.J. Funct. Foods,5,124-132.
12. Hsu, W.H.,Pan, T.M.(2014).A novel PPARgamma agonist monascin's potential application in diabetes prevention.Food Funct.,5,1334-1340.
13. Hsu, Y.W. Hsu, L.C. Chang, C.L. Liang, Y.H. Kuo, Y.H.,Pan, T.M.(2010).New anti-inflammatory and anti-proliferative constituents from fermented red mold rice Monascus purpureus NTU 568.Molecules,15,7815-7824.
14. Jukema, J.W.,Zwinderman, A.H.,Van Boven, A.J.,Reiber, J.H.,Van der Laarse, A.,Lie, K.I.,Bruschke, A.V.(1996).Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.Arterioscler. Thromb. Vasc. Biol.,16,425-430.
15. Lee, B.H.,Hsu, W.H.,Hsu, Y.W.,Pan, T.M.(2013).Dimerumic acid attenuates receptor for advanced glycation endproduct (RAGE) signal to inhibit inflammation and diabetes mediated by Nrf2 activation and promoted methylglyoxal metabolism into D-lactate acid.Free Radic. Biol. Med.,60,7-16.
16. Lee, C.L.,Hung, H.K.,Wang, J.J.,Pan, T.M.(2007).Red mold dioscorea has greater hypolipidemic and antiatherosclerotice effect than traditional red mold rice and unfermented dioscorea in hamsters.J. Agric. Food Chem.,55,7162-7169.
17. Lee, C.L.,Hung, Y.P.,Hsu, Y.W.,Pan, T.M.(2013).Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages.J. Agric. Food Chem.,61,143-150.
18. Lee, C.L.,Kung, Y.H.,Wu, C.L.,Hsu, Y.W.,Pan, T.M.(2010).Monascin and ankaflavin act as novel hypolipidemic and high-density lipoprotein cholesterol-raising agents in red mold dioscorea.J. Agric. Food Chem.,58,9013-9019.
19. Li, C.L.,Zhu, Y.,Wang, Y.Y.,Zhu, J.S.,Chang, J.,Kritchevsky, D.(1998).Monascus purpureus-fermented rice (red yeast): a natural product that lowers blood cholesterol in animal models of hypercholesterolemia.Nutr. Res.,18,71-81.
20. Messina, G.,Viggiano, A.,De Luca, V.,Messina, A.,Chieffi, S.,Monda, M.(2013).Hormonal changes in menopause and orexin-a action.Obstet. Gynecol. Int.,2013,209812.
21. Miura, K.,Daviglus, M.L.,Dyer, A.R.,Liu, K.,Garside, D.B.,Stamler, J.,Greenland, P.(2001).Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry.Arch. Intern. Med.,161,1501-1508.
22. Monda, M.,Messina, G.,Mangoni, C.,De Luca, B.(2008).Resting energy expenditure and fat-free mass do not decline during aging in severely obese women.Clin. Nutr.,27,657-659.
23. Monda, M.,Messina, G.,Vicidomini, C.,Viggiano, A.,Mangoni, C.,De Luca, B.(2006).Activity of autonomic nervous system is related to body weight in pre-menopausal, but not in post-menopausal women.Nutr. Neurosci.,9,141-145.
24. Orekhov, A.N.,Tertov, V.V.,Sobenin, I.A.,Akhmedzhanov, N.M.,Pivovarova, E.M.(1997).Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.Int. J. Cardiol.,62,67-77.
25. Psaty, B.M.,Lumley, T.,Furberg, C.D.,Schellenbaum, G.,Pahor, M.,Alderman, M.H.,Weiss, N.S.(2003).Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.J. Am. Med. Assoc.,289,2534-2544.
26. Shi, Y.C.,Pan, T.M.(2010).Characterization of a multifunctional Monascus isolate NTU 568 with high azaphilone pigments production.Food Biotechnol.,24,349-363.
27. Tertov, V.V.,Sobenin, L A. Gabbasov, Z.A.,Popov, E.G.,Yaroslavov, A.A.,Smirnov, V.N.(1992).Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.Circ. Res.,71,218-228.
28. Virdis, A.,Neves, M.F.,Amiri, F.,Touyz, R.M.,Schiffrin, E.L.(2004).Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.J. Hypertens.,22,535-542.